Neville Rodie & Shaw Inc / TMO
Neville Rodie & Shaw Inc’s Thermo Fisher Scientific Inc Position
Does Neville Rodie & Shaw Inc own Thermo Fisher Scientific Inc (TMO)? Yes — 55.1K shares worth $28M (+1.79% of its 13F portfolio) as of Q2 2026, down from 57.1K shares the prior filed quarter.
Position Value
$28M
Q2 2026
Shares
55.1K
% of Portfolio
+1.79%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 55.1K | $28M | +1.79% |
| Q1 2026 | 57.1K | $28M | +2.04% |
| Q4 2025 | 56.9K | $33M | +2.33% |
| Q3 2025 | 56.0K | $27M | +1.96% |
| Q2 2025 | 65.5K | $27M | +1.97% |
| Q1 2025 | 74.3K | $37M | +2.90% |
| Q4 2024 | 78.8K | $41M | +2.99% |
| Q3 2024 | 79.3K | $49M | +3.61% |
| Q2 2024 | 82.9K | $46M | +3.48% |
| Q1 2024 | 84.8K | $49M | +3.76% |
| Q4 2023 | 84.5K | $45M | +3.67% |
| Q3 2023 | 84.5K | $43M | +3.81% |
| Q2 2023 | 85.0K | $44M | +3.82% |
| Q1 2023 | 85.0K | $49M | +4.44% |
| Q4 2022 | 87.0K | $48M | +4.50% |
| Q3 2022 | 89.5K | $45M | +4.46% |
| Q2 2022 | 89.8K | $49M | +4.37% |
| Q1 2022 | 91.1K | $54M | +4.01% |
| Q4 2021 | 92.1K | $61M | +4.35% |
| Q3 2021 | 93.0K | $53M | +4.13% |
| Q2 2021 | 93.5K | $47M | +3.63% |
| Q1 2021 | 94.0K | $43M | +3.55% |
| Q3 2020 | 104.2K | $46M | +4.34% |
| Q2 2020 | 105.0K | $38M | +3.93% |
| Q1 2020 | 107.4K | $30M | +3.71% |
| Q4 2019 | 108.8K | $35M | +3.47% |
| Q3 2019 | 110.5K | $32M | +3.41% |
| Q2 2019 | 110.1K | $32M | +3.42% |
| Q1 2019 | 110.6K | $30M | +3.21% |
| Q4 2018 | 111.9K | $25M | +3.04% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neville Rodie & Shaw Inc’s full portfolio or all institutional holders of TMO.